Additional Relevant Details
- Data from Phase 3 randomized, placebo controlled trial demonstrates that 46.6 percent of adult patients with moderate to severe psoriasis treated with HUMIRA achieved at least a 75 percent improvement in their moderate to severe fingernail psoriasis 
- Fingernail psoriasis occurs in up to 55 percent of people living with psoriasis and up to 70 percent of people living with psoriatic arthritis(1)